Surgical strategy in BRCA-associated breast cancer. Clinical case-Reference-Cited by-同舟云学术

Surgical strategy in BRCA-associated breast cancer. Clinical case

Published:2021-12-07 Issue:1 Volume:1 Page:87-92
ISSN:2782-3202
Container-title:MD-Onco
language:
Short-container-title:jour

Author:

Lyubchenko L. N.¹^ORCID,Zelenova E. E.²^ORCID,Suglobova A. A.³,Zhordaniya K. I.³,Davydov M. M.⁴^ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; National Medical Research Center of Radiology, Ministry of Health of Russia

2. National Medical Research Center of Radiology, Ministry of Health of Russia

3. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

4. I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

Publisher

Publishing House ABV Press

Reference28 articles.

1. The state of oncological care to the population of Russia in 2017. Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: MNIOI n. a. P.A. Herzen – branch of the FSBI “NMIRC” of the Ministry of Health of Russia, 2018. 236 p. (In Russ.)

2. Heemskerk-Gerritsen B.A., Seynaeve C., Van Asperen C.J. et al. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst 2015;107(5):djv033. DOI: 10.1093/jnci/djv033.

3. Brose M.S., Rebbeck T.R., Calzone K.A. et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002;94(18):1365–72. DOI: 10.1093/jnci/94.18.1365.

4. Ford D., Easton D.F., Stratton M. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62(3):676–89. DOI: 10.1086/301749.

5. Lakhani S.R., Manek S., Penault-Llorca F. et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res 2004;10(7):2473–81. DOI: 10.1158/1078-0432.ccr-1029-3.